Unapproved and Misleaded Compounded GLP-1s
Dr. Marty Makary Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Re: Support for FDA Action to Address Unapproved and Misleading Compounded GLP-1 Drugs Dear Commissioner Makary: We write to applaud the FDA’s February 6, 2026 announcement to take decisive action against mass-marketed, non-FDA-approved GLP-1 drugs that put patients at risk. The Agency’s clear signal that it intends to use its enforcement authority was a welcome development in the face of so many flagrant violations by compounders. Your statement reinforces a foundational principle: companies may not mass-produce and mass-market, either online or in-person, [...]
Armed Forces Access to Obesity Care and Services
The Honorable Pete Hegseth United States Secretary of War 1000 Defense Pentagon Washington, DC 20301-1000 Dear Secretary Hegseth, The members of the United States Armed Forces are the collective cornerstone of American freedom and prosperity, and their health and fitness are paramount to our national defense. We applaud your commitment to improving the strength of our warfighters as they protect the American people and homeland. As you have emphasized, rising rates of overweight and obesity among U.S. military personnel pose an urgent threat to readiness, manpower, and the overall health of the force. In April 2024, the American Security Project [...]
FY27 Appropriations – NIH
The Honorable Mike Johnson, Speaker, U.S. House of Representatives Washington, DC 20515 The Honorable Hakeem Jeffries Minority Leader, U.S. House of Representatives Washington, DC 20515 The Honorable John Thune Majority Leader, U. S. Senate Washington, DC 20510 The Honorable Chuck Schumer Minority Leader, U.S. Senate Washington, DC 20510 Dear Speaker Johnson, Leader Jeffries, Leader Thune, and Leader Schumer: The undersigned organizations, including patient advocacy groups, professional scientific and medical societies, and other aligned stakeholders representing a broad range of medical and public health interests, write to urge the swift passage of [...]
BALANCE Model Statement
Jacqueline M. Stephens, PhD, FTOS, president of The Obesity Society (TOS), the leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement on the Centers for Medicare & Medicaid Services’ (CMS) launch of the BALANCE Model. “The BALANCE Model represents meaningful progress toward modernizing obesity care across Medicaid and Medicare Part D. Addressing drug costs and encouraging coordinated participation among state Medicaid programs and Medicare plans is an important step toward improving access to evidence-based treatment. While key details around implementation and eligibility remain to be defined, this effort reflects a necessary [...]
The Obesity Society Statement On New Dietary Guidelines
Rockville, MD - January 7, 2026 - Jacqueline M. Stephens, PhD, FTOS, President of The Obesity Society (TOS), the nation’s leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement regarding the recently issued updated Dietary Guidelines and their implications for obesity care. “The Obesity Society is concerned that the updated Dietary Guidelines do not reflect the modern scientific understanding of obesity as a chronic, complex disease, nor do they adequately address how eating behaviors and dietary patterns intersect with effective obesity prevention and treatment. While nutrition is an important foundation of health, [...]